These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7347793)

  • 21. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone histomorphometry of renal osteodystrophy in diabetic patients.
    Andress DL; Hercz G; Kopp JB; Endres DB; Norris KC; Coburn JW; Sherrard DJ
    J Bone Miner Res; 1987 Dec; 2(6):525-31. PubMed ID: 3455634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.
    Ferreira A; Saraiva M; Behets G; Macedo A; Galvão M; D'Haese P; Drüeke TB
    J Nephrol; 2009; 22(6):783-93. PubMed ID: 19967658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azotemic renal osteodystrophy; clinical features and bone pathology.
    Suzuki M; Hirasawa Y
    Endocrinol Jpn; 1979 Jun; 26(Suppl):85-93. PubMed ID: 467354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH; Faugere MC; Fanti P; Price PA
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
    Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
    Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy.
    Pecovnik Balon B; Bren A
    Clin Nephrol; 2000 Dec; 54(6):463-9. PubMed ID: 11140807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone histomorphometry in celiac disease.
    Arnala I; Kemppainen T; Kröger H; Janatuinen E; Alhava EM
    Ann Chir Gynaecol; 2001; 90(2):100-4. PubMed ID: 11459257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive diagnosis of uremic osteodystrophy: uses and limitations.
    Heaf JG; Joffe P; Pødenphant J; Andersen JR
    Am J Nephrol; 1987; 7(3):203-11. PubMed ID: 3631150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.
    Wang M; Hercz G; Sherrard DJ; Maloney NA; Segre GV; Pei Y
    Am J Kidney Dis; 1995 Nov; 26(5):836-44. PubMed ID: 7485142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.